Revuforj
Active substance: Revumenib
TABLET, FILM COATED · REVUMENIB CITRATE 110 mg/1
United StatesActive
Marketing holder: Syndax Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- REVUMENIB CITRATE · 110 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-f170-783a-83ff-48d9bef09b03,01a12095-1d5b-75f3-bc89-94d034c3d3b1,01a12097-530d-7926-8ee5-a39739c1cb79;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73555-501
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 73555-501 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73555-501 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73555-501 · Verified 2026-10-09 · open in source